Find a Clinical Trial

Showing 51 - 51 of 51 Trials
  • Principal Investigator:

    Ran Reshef, MD

    Contact Number:

    NCT Number:




    The purpose of this research study is to obtain information on the safety and effectiveness of PBCAR19B to treat certain types of cancers. PBCAR19B is a new investigational treatment for certain types of cancer of the blood, such as leukemia and lymphoma. It is made from a type of blood cells known as T cells. The T cells in PBCAR19B came from healthy people who have donated their blood. The donated T cells have been genetically changed, so that they may be able to kill some types of cancer cells. Additional genetic changes have been made to reduce the risk of these cells attacking your...